Actavis, Warner Chilcott In Merger Talks
Actavis Inc. and Warner Chilcott PLC confirmed Friday that they are in talks about a possible merger, one that would create a trans-Atlantic generic drug maker with $20 billion in combined...To view the full article, register now.
Already a subscriber? Click here to view full article